HIF-1α decreases the susceptibility of cancer cells to T-cell-mediated cytotoxicity, contributing to tumor immune escape by increasing CTLA-4 expression on CD8+ T cells and PD-L1 expression on hypoxic cancer cells (79). The gene discussed is HIF1A; the disease is neoplasm.